31.10.2011 - Swiss drugs industry supplier Lonza is set to grow underlying sales and operating profit this year despite the strong Swiss franc as it benefits from robust demand from...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)